Clare Gould
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Systemic diffuse large B-cell lymphoma involving the central nervous system has high rates of defective antigen presentation and immune surveillance.
Journal: Haematologica
Published: November 01, 2023
Observations from a national sample exchange program for molecular haematology testing.
Journal: Pathology
Published: July 25, 2023
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 15, 2022
Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target.
Journal: British journal of haematology
Published: May 17, 2021
The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.
Journal: European journal of haematology
Published: March 18, 2019
The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 23, 2016
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
Journal: The Lancet. Haematology
Published: February 02, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026